PTC Therapeutics

PTCT · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings about 1 month ago

Previous year: -$0.85

Previous year: $84.7M

Previous year: $1.14B

+70.7%

Total Assets

$2.9B

Previous year: $1.84B

+57.4%

Loading...

PTC Therapeutics

Unlock previous datapoints

Upgrade

PTC Therapeutics

Unlock previous datapoints

Upgrade

PTC Therapeutics Revenue by Segment

Revenue by Segment

Net Product Revenue

CapyFin.com

Collaboration & License Revenue

CapyFin.com

Royalty Revenue

CapyFin.com

Translarna Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Emflaza Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$5.34B

P/E Ratio

3.61

Sector

N/A

Industry

N/A

52-Week High

$86.1

52-Week Low

$36.1

GAAP R&D Expenses

$133M

GAAP SG&A Expenses

$96.9M

Non-GAAP R&D

$124M

Non-GAAP SG&A

$87.2M

Shares Outstanding

81.47M

Products

Get in Touch

Resources

PTC Therapeutics

PTC Therapeutics

PTC Therapeutics

PTC Therapeutics Revenue by Segment

Revenue by Segment

Net Product Revenue

Collaboration & License Revenue

Royalty Revenue

Translarna Revenue

Emflaza Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics